Hormonal and volume dysregulation in women with premenstrual syndrome

Hypertension

Volumn 51, Issue 4 PART 2 SUPPL., 2008, Pages 1225-1230

  Rosenfeld, Rimma ^a   Livne, Dana ^a   Nevo, Ori ^a   Dayan, Lior ^a   Milloul, Victor ^a   Lavi, Shahar ^a   Jacob, Giris ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Aldosterone; Edema; Premenstrual syndrome; Renin; Sex hormones

Indexed keywords

ALDOSTERONE; RENIN; SEX HORMONE;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EDEMA; ENDOCRINE DISEASE; FEMALE; FLUID RETENTION; HEMODYNAMICS; HOMEOSTASIS; HUMAN; MENSTRUAL CYCLE; PLASMA RENIN ACTIVITY; PLASMA VOLUME; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL;

ADULT; ALDOSTERONE; EDEMA; ESTROGENS; FEMALE; HORMONES; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; PLASMA VOLUME; PREMENSTRUAL SYNDROME; PROGESTERONE; RENIN; WATER-ELECTROLYTE IMBALANCE;

EID: 40849100409     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.107136     Document Type: Article

References (35)

1. Johnson SR, McChesney C, Bean JA. Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behavior. J Reprod Med. 1988;33:340-346.
2. Ramcharan S, Love EJ, Fick GH, Goldfien A. The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: attributable risk and risk factors. J Clin Epidemiol. 1992;45:377-392.
3. Angst J, Sellaro R, Merikangas KR, Endicott J. The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr Scand. 2001;104:110-116.
4. Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology. 2003;28(suppl 3):1-23.
5. Mortola JF. Issues in the diagnosis and research of premenstrual syndrome. Clin Obstet Gynecol. 1992;35:587-598.
6. Reid RL, Yen SS. Premenstrual syndrome. Am J Obstet Gynecol. 1981;139:85-104.
7. Keye WR Jr. General evaluation of premenstrual symptoms. Clin Obstet Gynecol. 1987;30:396-407.
8. Seippel L, Eriksson O, Grankvist K, von Shoultz B, Backstrom T. Physical symptoms in premenstrual syndrome are related to plasma progesterone and desoxycorticosterone. Gynecol Endocrinol. 2000;14:173-181.
9. Taylor JW. Plasma progesterone, oestradiol 17 beta and premenstrual symptoms. Acta Psychiatr Scand. 1979;60:76-86.
10. Allen SS, McBride CM, Pirie PL. The shortened premenstrual assessment form. J Reprod Med. 1991;36:769-772.
11. Hirshoren N, Tzoran I, Makrienko I, Edoute Y, Plawner MM, Itskovitz-Eldor J, Jacob G. Menstrual cycle effects on the neurohumoral and autonomic nervous systems regulating the cardiovascular system. J Clin Endocrinol Metab. 2002;87:1569-1575.
12. Jacob G, Ertl AC, Shannon JR, Furlan R, Robertson RM, Robertson D. Effect of standing on neurohumoral responses and plasma volume in healthy subjects. J Appl Physiol. 1998;84:914-921.
13. Campagne DM, Campagne G. The premenstrual syndrome revisited. Eur J Obstet Gynecol Reprod Biol. 2007;130:4-17.
14. Guyton CA, Hall EJ. Female physiology before pregnancy; and the female hormones. In: Guyton CA and Hall EJ, ed. Text Book of Medical Physiology. Philadelphia, PA: Saunders;1996:1017-1032.
15. Facchinetti F, Genazzani AD, Martignoni E, Fioroni L, Nappi G, Genazzani AR. Neuroendocrine changes in luteal function in patients with premenstrual syndrome. J Clin Endocrinol Metab. 1993;76:1123-1127.
16. Lewis LL, Greenblatt EM, Rittenhouse CA, Veldhuis JD, Jaffe RB. Pulsatile release patterns of luteinizing hormone and progesterone in relation to symptom onset in women with premenstrual syndrome. Fertil Steril. 1995;64:288-292.
17. Frank R. The hormonal causes of premenstrual tension. Arch Neurol Psychiatry. 1931;26:1053-1057.
18. Monteleone P, Luisi S, Tonetti A, Bernardi F, Genazzani AD, Luisi M, Petraglia F, Genazzani AR. Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol. 2000;142:269-273.
19. Nyberg S, Backstrom T, Zingmark E, Purdy RH, Poromaa IS. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome. Gynecol Endocrinol. 2007;23:257-266.
20. O'Brien PM, Selby C, Symonds EM. Progesterone, fluid, and electrolytes in premenstrual syndrome. BMJ. 1980;280:1161-1163.
21. Hammarback S, Damber JE, Backstrom T. Relationship between symptom severity and hormone changes in women with premenstrual syndrome. J Clin Endocrinol Metab. 1989;68:125-130.
22. Jones EM, Fox RH, Verow PW, Asscher AW. Variations in capillary permeability to plasma proteins during the menstrual cycle. J Obstet Gynaecol Br Commonw. 1966;73:666-669.
23. Stachenfeld NS, Keefe DL, Palter SF. Estrogen and progesterone effects on transcapillary fluid dynamics. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1319-R1329.
24. Chapman AB, Zamudio S, Woodmansee W, Merouani A, Osorio F, Johnson A, Moore LG, Dahms T, Coffin C, Abraham WT, Schrier RW. Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol. 1997;273:F777-F782.
25. Hu X, Adamson RH, Liu B, Curry FE, Weinbaum S. Starling forces that oppose filtration after tissue oncotic pressure is increased. Am J Physiol Heart Circ Physiol. 2000;279:H1724-H1736.
26. Wong WH, Freedman RI, Levan NE, Hyman C, Quilligan EJ. Changes in the capillary filtration coefficient of cutaneous vessels in women with premenstrual tension. Am J Obstet Gynecol. 1972;114:950-953.
27. Virdis A, Ghiadoni L, Pinto S, Lombardo M, Petraglia F, Gennazzani A, Buralli S, Taddei S, Salvetti A. Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women. Circulation. 2000;101:2258-2263.
28. Myles K, Funder JW. Progesterone binding to mineralocorticoid receptors: in vitro and in vivo studies. Am J Physiol. 1996;270:E601-E607.
29. Szmuilowicz ED, Adler GK, Williams JS, Green DE, Yao TM, Hopkins PN, Seely EW. Relationship between aldosterone and progesterone in the human menstrual cycle. J Clin Endocrinol Metab. 2006;91:3981-3987.
30. Chidambaram M, Duncan JA, Lai VS, Cattran DC, Floras JS, Scholey JW, Miller JA. Variation in the renin angiotensin system throughout the normal menstrual cycle. J Am Soc Nephrol. 2002;13:446-452.
31. Davidson BJ, Rea CD, Valenzuela GJ. Atrial natriuretic peptide, plasma renin activity, and aldosterone in women on estrogen therapy and with premenstrual syndrome. Fertil Steril. 1988;50:743-746.
32. Munday M, Brush MG, Taylor RW. Progesterone and aldosterone levels in the premenstrual tension syndrome [proceedings]. J Endocrinol. 1977;73:21P-22P.
33. Vellacott ID, Shroff NE, Pearce MY, Stratford ME, Akbar FA. A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome. Curr Med Res Opin. 1987;10:450-456.
34. Wang M, Hammarback S, Lindhe BA, Backstrom T. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study. Acta Obstet Gynecol Scand. 1995;74:803-808.
35. Masho SW, Adera T, South-Paul J. Obesity as a risk factor for premenstrual syndrome. J Psychosom Obstet Gynaecol. 2005;26:33-39.